KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 60 filers reported holding KINNATE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 70,000 | $98,000 | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,201 | $2 | 0.00% |
| GROUP ONE TRADING, L.P. | 300 | $420 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 221,514 | $310,187 | 0.00% |
| STATE STREET CORP | 61,959 | $86,743 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 557,258 | $780,161 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,706 | $14,989 | 0.00% |
| DEUTSCHE BANK AG\ | 114,846 | $160,784 | 0.00% |
| CITIGROUP INC | 420,585 | $588,819 | 0.00% |
| GOLDMAN SACHS GROUP INC | 78,971 | $110,559 | 0.00% |
| MORGAN STANLEY | 23,138 | $32,392 | 0.00% |
| BlackRock Inc. | 741,350 | $1,037,890 | 0.00% |
| Citadel Advisors | 2,500 | $3,500 | 0.00% |
| Citadel Advisors | 1,900 | $2,660 | 0.00% |
| Citadel Advisors | 1,059,843 | $1,483,781 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 145,478 | $203,669 | 0.00% |
| TWO SIGMA ADVISERS, LP | 107,000 | $149,800 | 0.00% |
| Daiwa Securities Group Inc. | 127 | $0 | 0.00% |
| Quantbot Technologies LP | 2,700 | $3,780 | 0.00% |
| Qube Research & Technologies Ltd | 4,621 | $6,469 | 0.00% |
External links
This page lists KINNATE BIOPHARMA INC's shareholders in Q3 2023. To view KINNATE BIOPHARMA INC's shareholder history, click here.